Emerald Mutual Fund Advisers Trust’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-680,588
| Closed | -$1.91M | – | 255 |
|
|
2022
Q4 | $1.91M | Sell |
680,588
-401,515
| -37% | -$1.13M | 0.12% | 126 |
|
|
2022
Q3 | $4.49M | Buy |
1,082,103
+37,371
| +4% | +$155K | 0.28% | 104 |
|
|
2022
Q2 | $4.2M | Sell |
1,044,732
-48,416
| -4% | -$195K | 0.24% | 112 |
|
|
2022
Q1 | $5.41M | Buy |
1,093,148
+95,922
| +10% | +$475K | 0.24% | 117 |
|
|
2021
Q4 | $6.95M | Buy |
997,226
+621,420
| +165% | +$4.33M | 0.25% | 113 |
|
|
2021
Q3 | $3.76M | Sell |
375,806
-942,931
| -72% | -$9.43M | 0.13% | 136 |
|
|
2021
Q2 | $18.7M | Sell |
1,318,737
-35,159
| -3% | -$499K | 0.61% | 67 |
|
|
2021
Q1 | $22.2M | Buy |
1,353,896
+232,268
| +21% | +$3.81M | 0.74% | 54 |
|
|
2020
Q4 | $23.2M | Buy |
+1,121,628
| New | +$23.2M | 0.81% | 46 |
|